跳至主要内容
临床试验/NL-OMON32343
NL-OMON32343已完成4 期

Inhibition of platelet activation by clopidogrel in type II diabetes mellitus patients - clopi2008

niversitair Medisch Centrum Utrecht0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. healthy controls (matched by age and gender)
  • 2. type II DM patients, treated with oral bloodglucose lowering agents (biguanides or sulfonylurea derivates)

排除标准

  • pregnancy; use of anti-epileptic drugs; use of acetylsalicylacid, NSAID, GPIIb-IIa antagonists, heparin or thrombolytica; known diabetic retinopathy; smoking; hypersensitivity to the drug substance or any component of the product; severe liverfunctiondisorder; active pathological bleeding such as peptic ulcer or intracranial hemorrhage; breastfeeding; surgery or dental operation 7 days prior or 7 days after the start of clopidogrel intake; galactose intolerance, lapp lactase deficiency or glucose galactose malabsorbtion

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

进行中(未招募)
不适用
Assessing Platelet Inhibitory Response to Clopidogrel – Feasibility, Safety and Cost Analysis of a Tailored Platelet Inhibition Strategy for Elective PCI Patients - Plavix and PrasugrelTo investigate the feasibility, safety and cost of using the platelet assay VerifyNow-P2Y12 to guide optimal P2Y12 platelet inhibition in patients undergoing elective PCI, compared with standard treatment, at a UK tertiary referral cardiology centre.
EUCTR2010-018435-18-GBPapworth Hospital NHS Foundation Trust200
Unknown
不适用
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3AThrombosisHypercholesterolemia
NCT00004564National Center for Research Resources (NCRR)
已完成
不适用
High-on Clopidogrel Platelet Reactivity as Assessed by Thromboelastography in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.I21I25I26Chronic ischaemic heart diseaseAcute myocardial infarctionPulmonary embolism
DRKS00024509Kardiologie und Angiologie172
进行中(未招募)
1 期
Assessment of platelet inhibitory response to clopidogrel when coadministered with a proton pump inhibitor - Plavix and PPI study
EUCTR2009-011543-40-GBPapworth Hospital72
已完成
不适用
Platelet response to prasugrel and clopidogrel loadinig doses in elective PCI patientsElective PCI
JPRN-UMIN000017624Division of Cardiovascular Medicine, Jichi Medical University School of Medicine40
Inhibition of platelet activation by clopidogrel in... | 临床试验